design

Topic	Replies	Views	Activity
Designing numerical stimuli	0	2430	July 7, 2021
Default Using R package to implement Bayesian phase I/II dose-finding design for three outcomes design , bayes , statistical-model , rct , prediction	10	3463	June 10, 2021
Bootstrap and prior distribution method for self-controlled case series design design	0	2126	June 9, 2021
Fully sequential Bayesian clinical trial design for in-hospital treatment of COVID-19 bayes , ordinal , covid-19	23	11317	June 7, 2021
Debunking myths: intention to treat , missing follow-up and imputation missing-data , itt	6	3561	March 15, 2021
Sample size requirements for a proportional odds model ordinal , sample-size	7	5982	March 15, 2021
Devising a database	7	4985	February 23, 2021
Value stream mapping - numbers needed power	0	2748	February 8, 2021
Power Analysis for 3 Groups and 3 Measures power , sample-size	1	3407	February 7, 2021
DAGs for Bayesian hierarchical models? causal	4	6965	January 8, 2021
Sample size estimation sample-size	6	5171	November 14, 2020
RCT trials for COVID study vaccines design , rct	0	3083	October 24, 2020
"Open label, double-masked trial" rct	0	3332	October 13, 2020
Bayesian solution for study designs design , bayes	0	3083	September 24, 2020
Factorial design - dropping factors and conditions	1	2311	September 1, 2020
Re-starting a Bayesian group sequential design trial after stopping it bayes , rct , prediction	4	2894	August 11, 2020
Stratification, block-randomization, etc randomization	6	5548	August 4, 2020
Multiplicity in AIM-NIVO trial, uncontrolled by statistical discipline	0	2662	June 12, 2020
Seeking advice on Ethics and Efficiency of testing safety in a curative setting? ethics	4	3330	May 31, 2020
When is censoring too high? time-to-event , censoring	11	15564	May 28, 2020
Random vs. stratified sampling in estimating a varying treatment effect	0	2216	May 14, 2020
Self controlled case series	1	2979	May 6, 2020
COVID-19 Research Methods Resources covid-19	10	11222	May 4, 2020
Sample size calculation for intraclass correlation coefficient (ICC) sample-size , observer-variability	0	4201	May 1, 2020
Are hospital based retrospective cohort studies subject to Berkson's Bias?	1	2193	April 22, 2020
Illness Severity among Non-COVID patients ordinal , bayes , covid-19	11	8291	April 19, 2020
Does Bayesian analysis render the 'primary endpoint' as irrelevant as multiplicity? bayes , multiplicity	8	4264	April 10, 2020
Power calculations for cluster-RCT in hospital infection control (PPE for Covid19) power , covid-19 , cluster-randomize , sample-size	6	5108	April 1, 2020
Type I error in a specific design of 2-parallel group study design , bayes , rct , drop-treatment-arm , dose-escalation	3	3579	March 11, 2020
Comparing continuous outcome in case-control-style design epi	2	2849	March 6, 2020